13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Acne Vulgaris D000152 35 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Zhu J et al. [3 retinoic acid isomers on proliferation and differentiation properties of APL cell line-NB4]. 1995 Zhonghua Yi Xue Za Zhi pmid:7780822
Tang SQ et al. [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid]. 2004 Zhonghua Er Ke Za Zhi pmid:15324562
Jiang XG and Xi NZ [A reversed-phase HPLC method for determining tretinoin]. 1994 Zhongguo Yao Li Xue Bao pmid:7717076
Liu CZ et al. [Randomized control study on the treatment of 26 cases of acne conglobata with encircling acupuncture combined with venesection and cupping]. 2008 Zhen Ci Yan Jiu pmid:19288903
Melnik B and Plewig G [New lipid biochemical aspects in the pathogenesis of a follicular keratinization disorder in acne vulgaris]. 1988 Z. Hautkr. pmid:2973184
Mayerhausen W and Riebel B [Acne fulminans following use of anabolic steroids]. 1989 Z. Hautkr. pmid:2531507
Park YK et al. Pachydermoperiostosis: trial with isotretinoin. 1988 Yonsei Med. J. pmid:3064439
Lee SM et al. A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug. 2009 Yonsei Med. J. pmid:19568610
Wang QF et al. [The preparation and kinetic study on enzymatically-controlled drug release of isotretinoin/amylose inclusion complex]. 2012 Yao Xue Xue Bao pmid:23227555
Vane FM et al. Human biliary metabolites of isotretinoin: identification, quantification, synthesis, and biological activity. 1990 Xenobiotica pmid:2333716
Kontaxakis VP et al. Genetic vulnerability and isotretinoin-induced psychiatric adverse events. 2010 World J. Biol. Psychiatry pmid:20109108
Ng CH et al. Acne, isotretinoin treatment and acute depression. 2001 World J. Biol. Psychiatry pmid:12587200
Atzpodien J et al. Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid. 1995 World J Urol pmid:7550391
Duda-Król W et al. [A probe using isotretinoin for treatment of poorly differentiated leukemia]. 1996 Wiad. Lek. pmid:9245116
Bergler-Czop B and Brzezińska-Wcisło L [Recurrence in patients diagnosed with acne treated by isotretinoin and other methods]. 2006 Wiad. Lek. pmid:16813256
Kaniewski M et al. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid]. 2001 Wiad. Lek. pmid:12182038
Handkiewicz-Junak D et al. [Use of 13-cis retinoic acid for treatment of advanced differentiated thyroid cancer]. 2001 Wiad. Lek. pmid:12182039
Tallab T et al. Isotretinoin therapy: any need for laboratory assessment? 2004 Oct-Dec West Afr J Med pmid:15730082
Garattini E et al. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents. 2007 Vitam. Horm. pmid:17368321
Toma S and Noli C Isotretinoin in the treatment of multiple benign pilomatrixomas in a mixed-breed dog. 2005 Vet. Dermatol. pmid:16238816
MashkilleÄ­son AL and ZaÄ­tseva SIu [Roaccutan in the treatment of severe forms of acneiform eruption]. 1989 Vestn Dermatol Venerol pmid:2532821
Gromova SA et al. [Roaccutan in the therapy of severe manifestations of acne vulgaris and rosacea]. 1989 Vestn Dermatol Venerol pmid:2534455
Page DG et al. An alternative approach to the treatment of oral leukoplakia. 1995 Apr-Jun Va Dent J pmid:9540748
Healy B Pledging for accutane. 2005 US News World Rep pmid:16159042
Cardamakis E et al. Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. 1995 Urology pmid:7747375
Rossen MH and Roed-Petersen J [Acne vulgaris]. 1993 Ugeskr. Laeg. pmid:8460427
Søderberg U and Thestrup-Pedersen K [Fulminant acne]. 1993 Ugeskr. Laeg. pmid:8328051
Jemec GB [Treatment of acne]. 2000 Ugeskr. Laeg. pmid:11187138
Halkier-Sørensen L and Andresen JH [Bone changes following long-term isotretinoin (Roaccutane) treatment]. 1989 Ugeskr. Laeg. pmid:2734898
Jensen JB [Isotretinoin (Roaccutan) and depression]. 1998 Ugeskr. Laeg. pmid:9859736
Ceviz N et al. A case of isotretinoin embryopathy with bilateral anotia and Taussig-Bing malformation. 2000 Jul-Sep Turk. J. Pediatr. pmid:11105626
Kiliç E et al. Isotretinoin (13-cis-retinoic acid)-associated premature ventricular contractions. 2009 Jul-Aug Turk. J. Pediatr. pmid:19950851
Tankurt E et al. Esophageal ulcers: a possible adverse effect of isotretinoin. 2013 Turk J Gastroenterol pmid:24623299
Vitamin A type drug for Kaposi's sarcoma (KS). 1995 Treat Rev pmid:11363023
Bellman BA et al. Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. 1996 Transplantation pmid:8560565
Kiss E et al. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. 2003 Transplantation pmid:12923432
Stinson SF et al. Atrophy induced in the tubules of the testes of Syrian hamsters by two retinoids. 1980 Toxicology pmid:6938081
Kameoka S et al. A high-throughput screen for teratogens using human pluripotent stem cells. 2014 Toxicol. Sci. pmid:24154490
Wang K et al. Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. 2006 Toxicol. Sci. pmid:16632523
Rühl R et al. Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization. 2001 Toxicol. Sci. pmid:11509747
Ferguson SA et al. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. 2005 Toxicol. Sci. pmid:16033993
Macejová D et al. Different mRNA expression profiling of nuclear retinoid, thyroid, estrogen and PPARgamma receptors, their coregulators and selected genes in rat liver and spleen in response to short-term in vivo administration of 13-cis retinoic acid. 2009 Toxicol. Lett. pmid:19041696
Ratajewski M et al. Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. 2015 Toxicol. Lett. pmid:25455453
Willhite CC et al. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223. 2000 Toxicol. Appl. Pharmacol. pmid:10764630
Collins MD et al. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats. 1994 Toxicol. Appl. Pharmacol. pmid:8048045
Tzimas G et al. Developmental stage-associated differences in the transplacental distribution of 13-cis- and all-trans-retinoic acid as well as their glucuronides in rats and mice. 1995 Toxicol. Appl. Pharmacol. pmid:7597714
Eckhoff C and Willhite CC Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters. 1997 Toxicol. Appl. Pharmacol. pmid:9299599
Eckhoff C et al. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits. 1994 Toxicol. Appl. Pharmacol. pmid:8128493
Silva FS et al. The in vitro and in vivo genotoxicity of isotretinoin assessed by cytokinesis blocked micronucleus assay and comet assay. 2013 Toxicol In Vitro pmid:23318729
Rødland O and Helland S [Hypertrophic granulation tissue as a complication to isotretinoin treatment]. 1991 Tidsskr. Nor. Laegeforen. pmid:1835182
Hansen SR et al. Systemic treatment of acne. 2011 Tidsskr. Nor. Laegeforen. pmid:21267031
Berg G et al. Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and retinoic acid. 2005 Thyroid pmid:16405414
Masood MQ and Hakeem H Isotretinoin associated reversible hypothyroidism. 2011 Thyroid pmid:21834674
Coelho SM et al. Isotretinoin as a diagnostic tool for localization of thyroid tissue in a thyroid cancer patient: a case report. 2007 Thyroid pmid:17956163
Wallnöfer AE et al. Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans. 1993 Thromb. Haemost. pmid:8165591
Pernod G et al. Retinoids induced t-PA synthesis by C6 glioma cells--role in tumoral haemorrhagic necrosis. 1996 Thromb. Haemost. pmid:8815586
Veal G et al. Pharmacokinetics and pharmacogenetics of 13-cis-retinoic acid in the treatment of neuroblastoma. 2007 Mar-Apr Therapie pmid:17582307
Choquet-Kastylevsky G et al. [Recurrent subcutaneous edema induced by isotretinoin]. 1999 Mar-Apr Therapie pmid:10394267
Rouzès A and Jonville-Béra AP [Exposure to isotretinoin during pregnancy in France: 25 years of follow-up]. 2014 Jan-Feb Therapie pmid:24698189
Amalfitano G et al. [Risk of intracerebral hematoma and profibrinolytic activity of isotretinoin]. 1995 Sep-Oct Therapie pmid:8571296
Taillan B et al. [Paroxysmal nocturnal hemoglobinuria and hemolysis induced by isotretinoin]. 1994 Sep-Oct Therapie pmid:7855773
Gerny H [Current therapy of acne vulgaris]. 1989 Ther Umsch pmid:2522686
Lübbe J and Harms M [Therapy of acne vulgaris]. 1998 Ther Umsch pmid:9757813
Ortolon K A pox on your practice. iPLEDGE program scars dermatologists. 2006 Tex Med pmid:17115578
Lynberg MC et al. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance. 1990 Teratology pmid:2278026
Honein MA et al. Continued occurrence of Accutane-exposed pregnancies. 2001 Teratology pmid:11514944
Kassis I et al. Isotretinoin (Accutane) and pregnancy. 1985 Teratology pmid:3862261
Hart RC et al. Avian model for 13-cis-retinoic acid embryopathy: morphological characterization of ventricular septal defects. 1992 Teratology pmid:1290153
Werler MM et al. Maternal vitamin A supplementation in relation to selected birth defects. 1990 Teratology pmid:2278025
Lee QP et al. Microinjection of cultured rat embryos: studies with retinol, 13-cis- and all-trans-retinoic acid. 1991 Teratology pmid:1948766
Recommendations for isotretinoin use in women of childbearing potential. 1991 Teratology pmid:1957255
Sulik KK and Dehart DB Retinoic-acid-induced limb malformations resulting from apical ectodermal ridge cell death. 1988 Teratology pmid:3165225
Burk DT and Willhite CC Inner ear malformations induced by isotretinoin in hamster fetuses. 1992 Teratology pmid:1440418
Ritchie H and Webster WS Parameters determining isotretinoin teratogenicity in rat embryo culture. 1991 Teratology pmid:2006473
Rosa FW et al. Teratogen update: vitamin A congeners. 1986 Teratology pmid:3461576
Robertson JA et al. Accutane cases: a teratogen information service's approach. 2002 Teratology pmid:12115772
Irving DW et al. Morphogenesis of isotretinoin-induced microcephaly and micrognathia studied by scanning electron microscopy. 1986 Teratology pmid:3465061
Kubow S Inhibition of isotretinoin teratogenicity by acetylsalicylic acid pretreatment in mice. 1992 Teratology pmid:1731396
Korte R et al. Importance of early exposure to 13-cis retinoic acid to induce teratogenicity in the cynomolgus monkey. 1993 Teratology pmid:8475456
Källén B Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin. 1999 Teratology pmid:10440771
Therapeutic Teratology: the 1996 Teratology Society Public Affairs Symposium. 1996 Teratology pmid:9098924
Rizzo R et al. Limb reduction defects in humans associated with prenatal isotretinoin exposure. 1991 Teratology pmid:1805430
Kwasigroch TE and Bullen M Effects of isotretinoin (13-cis-retinoic acid) on the development of mouse limbs in vivo and in vitro. 1991 Teratology pmid:1805431
Kochhar DM and Penner JD Developmental effects of isotretinoin and 4-oxo-isotretinoin: the role of metabolism in teratogenicity. 1987 Teratology pmid:3478842
Hummler H et al. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey. 1994 Teratology pmid:7871482
Makori N et al. 13-cis-retinoic acid causes patterning defects in the early embryonic rostral hindbrain and abnormal development of the cerebellum in the macaque. 2001 Teratology pmid:11241428
Hummler H et al. Induction of malformations in the cynomolgus monkey with 13-cis retinoic acid. 1990 Teratology pmid:2274892
Kochhar DM et al. Placental transfer and developmental effects of 9-cis retinoic acid in mice. 1995 Teratology pmid:7570368
Tzimas G et al. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid. 1996 Teratology pmid:9035347
Creech Kraft J et al. Isotretinoin (13-cis-retinoic acid) metabolism, cis-trans isomerization, glucuronidation, and transfer to the mouse embryo: consequences for teratogenicity. 1991 Teratog., Carcinog. Mutagen. pmid:1677495
Torabi B and Shemirani F A new approach to highly sensitive determination of retinoic acid isomers by preconcentration with CdSe quantum dots. 2014 Talanta pmid:24468339
Browning DJ and Proia AD Ocular rosacea. 1986 Nov-Dec Surv Ophthalmol pmid:2433782
Louryan S et al. Induced and genetic mouse middle ear ossicular malformations: a model for human malformative ossicular diseases and a tool for clarifying their normal ontogenesis. 1992 Surg Radiol Anat pmid:1440187
Dunst J et al. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers. 1998 Strahlenther Onkol pmid:9830438
Bläse M et al. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity. 1999 Strahlenther Onkol pmid:10584127
Jones G and Rocke DM Multivariate survival analysis with doubly-censored data: application to the assessment of Accutane treatment for fibrodysplasia ossificans progressiva. 2002 Stat Med pmid:12205698
Shih WJ et al. Analysis of pilot and early phase studies with small sample sizes. 2004 Stat Med pmid:15195318
Varghese SJ et al. In vitro interaction study of retinoic acid isomers with telmisartan and amlodipine by equilibrium dialysis method using UV spectroscopy. 2011 Spectrochim Acta A Mol Biomol Spectrosc pmid:21489865
Wooten J Adverse drug reactions. 2006 South. Med. J. pmid:17004521
Millan SB et al. Isotretinoin. 1987 South. Med. J. pmid:2951855